News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
69 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (3795)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4259)
October (5135)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Pharm Country
Motif Bio Announces Filing of U.S. Shelf Registration
The filing of a shelf registration statement is intended to provide the Company with more timely and efficient access to the U.S. capital markets.
January 19, 2018
·
6 min read
Bavarian Nordic Announces Initiation of Clinical Trial With Novel Cancer Immunotherapy Targeting Brachyury in Cancer Metastasis
The trial will enroll up to 10 patients with metastatic or unresectable, locally advanced malignant solid tumors.
January 19, 2018
·
4 min read
Policy
Santhera Plans to Announce Regulatory Feedback for Raxone in DMD and 2017 Preliminary Key Financial Figures
Santhera expects to receive an opinion by the CHMP of the EMA for its MAA filed as Type II extension application for Raxone in DMD by January 26.
January 19, 2018
·
3 min read
Technical University of Munich Release: Piecework at the Nano Assembly Line
Scientists at LMU and TUM have developed a novel electric propulsion technology for nanorobots.
January 19, 2018
·
3 min read
HTG Molecular Diagnostics Announces Pricing of Public Offering of Common Stock
The offering is expected to close on January 23, 2018, subject to customary closing conditions.
January 19, 2018
·
3 min read
Biotech Bay
Veracyte’s Chief Science and Medical Officer to Present at The Precision Medicine World Conference
The PMWC is being held January 22-24 at the Computer History Museum in Mountain View, Calif.
January 19, 2018
·
4 min read
Drug Development
Reata Announces the Publication of Efficacy Data From the Beacon Study of Bardoxolone in Diabetic CKD in the American Journal of Nephrology
The publication complements previously published safety analyses and reports efficacy analyses that characterize bardoxolone’s longer-term effects on kidney function.
January 19, 2018
·
5 min read
Deals
Tauriga Sciences Completes Its Purchase of Crypto Currency Groestlcoin
The Company today confirms that it has purchased $25,000 worth of crypto currency Groestlcoin and owns a total of 13,033.8579 GRS Units.
January 19, 2018
·
3 min read
Business
Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee
He has served as Deputy CFO and Head of Finance Operations and Group Controlling since January 1st, 2016.
January 19, 2018
·
3 min read
Drug Development
AVEO Oncology Announces Presentation of Data from Phase Ib/II Study of Tivozanib in Patients with Advanced Hepatocellular Carcinoma
There were no significant changes in HBV or HCV viral load during study treatment. Tivozanib was generally well tolerated at 1.0 mg daily, with adverse events consistent with those observed in previous tivozanib trials.
January 19, 2018
·
7 min read
Previous
3 of 7
Next